Parliamentary Search

Written question asked by Baroness McIntosh of Pickering (Conservative) on Thursday, 12 November 2020, in the House of Lords. It was due for an answer on Thursday, 26 November 2020. It was answered by Lord Bethell (Conservative) on Monday, 30 November 2020 on behalf of the Department of Health and Social Care.

Coronavirus: Vaccination

Question

To ask Her Majesty's Government what assessment they have made of the potential reliance on paracetamol in alleviating possible side effects of the COVID-19 vaccination; what plans they have to ensure that patients in rural areas can access such medication where there is no community pharmacy in place; and whether rural dispensing practices will be permitted to sell sufficient quantities of such medication.

Answer

Assessments on the potential reliance on medication in alleviating possible side effects of the COVID-19 vaccination are not finalised as we do not yet know the full characteristics, including side effects, of any of the vaccines in development. All plans for deployment remain flexible as there are no certainties in the development, production, formulation and timing of any new vaccines.

Detailed planning is underway building on the National Health Service’s expertise to deliver immunisation programmes, such as the flu vaccination programme. Planning considerations, includes the supporting infrastructure required, including warehousing, transport, logistics for transport across the nation and end-destination ‘clinic’ storage.

Medication such as paracetamol can also be purchased from supermarkets and other retail outlets, as a ‘general sales’ medicine. Paracetamol can also be purchased online, including in a larger quantity from an online pharmacy.

Secondary information

Type
Written question
Reference
HL10303
Session
2019-21
Subjects
Pharmacy Vaccination Rural areas Side effects Paracetamol Coronavirus
Link
View this Written question on www.parliament.uk